Efficient bio-catalytic production of enentiopure (S)-(4-chlorophenyl) (phenyl)methanol as a drug precursor by using a novel rotatable composite design-based optimization strategy
dc.contributor.author | Tozlu, Nesrullah | |
dc.contributor.author | Bulbul, Ali Savas | |
dc.contributor.author | Ozdemir, Akin | |
dc.contributor.author | Sahin, Engin | |
dc.date.accessioned | 2024-10-04T18:49:41Z | |
dc.date.available | 2024-10-04T18:49:41Z | |
dc.date.issued | 2023 | |
dc.department | Bayburt Üniversitesi | en_US |
dc.description.abstract | Asymmetric bioreductions catalyzed by biocatalysts have demonstrated great promise in manufacturing chiral alcohols. On the other hand, the synthesis of (S)-(4-chlorophenyl)(phenyl)methanol ((S)-2), precursors of Lcloprastine and carbinoxamine, still presents considerable challenges due to the inadequate substrate quantity and production process. In this work, a novel rotatable composite design-based optimization technique was used with the Lactobacillus paracasei BD101 biocatalyst for the asymmetric reduction of (4-chlorophenyl)(phenyl) methanone (1). Optimization conditions of the reaction were determined by the proposed optimization strategy as: pH=5.85, temperature=37 degrees C, incubation time=71 h, and agitation speed=120 rpm. The reaction conversion and the product of enantiomeric excess (ee) were also predicted to be 97% and 99%, respectively. In the experimental study performed under the determined optimized conditions, (S)-2 was obtained with >99% ee, >99% conversion, and 97% yield. In addition, 1 with the amount of 15.166 g was completely converted to (S)-2 (14.85 g, 97% isolated yield) on a high-gram scale. Notice that the manufacture of (S)-2 on a gram scale utilizing a biocatalyst and an optimization technique is demonstrated in this work for the first time. Finally, an economical, effective, and environmentally friendly biocatalytic process for the biocatalytic synthesis of (S)-2, which have antitussive and antiemetic properties and relax the bronchial muscle, has been demonstrated by the novel rotatable composite design-based optimization method. | en_US |
dc.identifier.doi | 10.1016/j.mcat.2023.113404 | |
dc.identifier.issn | 2468-8231 | |
dc.identifier.scopus | 2-s2.0-85166278445 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.mcat.2023.113404 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12403/3254 | |
dc.identifier.volume | 547 | en_US |
dc.identifier.wos | WOS:001047298500001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Molecular Catalysis | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Biocatalysis | en_US |
dc.subject | Drug precursor | en_US |
dc.subject | Asymmetric bioreduction | en_US |
dc.subject | Green chemistry | en_US |
dc.subject | (s)-(4-chlorophenyl)(phenyl)methanol | en_US |
dc.title | Efficient bio-catalytic production of enentiopure (S)-(4-chlorophenyl) (phenyl)methanol as a drug precursor by using a novel rotatable composite design-based optimization strategy | en_US |
dc.type | Article | en_US |